Sudden death in a patient with lamin A/C gene mutation and near normal left ventricular systolic function

Insights

Lamin A/C gene mutations can cause sudden cardiac death, even without severe heart dysfunction. Early consideration of implantable cardioverter-defibrillators is crucial for affected individuals.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Familial dilated cardiomyopathy (DCM) is often linked to mutations in the lamin A/C gene.
  • Lamin A/C gene mutations are associated with conduction disorders, atrial fibrillation, heart failure, and sudden cardiac death.

Observation:

  • A case of an asymptomatic 28-year-old man with an R190W lamin A/C mutation presenting with sudden cardiac death during sleep.
  • The patient exhibited mild left ventricular enlargement, preserved ejection fraction, and no initial conduction system disease on ECG.
  • A notable ECG finding was progressive voltage decrease, potentially indicating disease progression.

Findings:

  • Sudden cardiac death can occur in individuals with lamin A/C gene mutations prior to significant left ventricular dysfunction.
  • The R190W mutation in the lamin A/C gene was identified in the patient and his mother, who also experienced sudden death.

Implications:

  • This case highlights the risk of sudden cardiac death in lamin A/C mutation carriers, irrespective of overt cardiac dysfunction.
  • Early implantation of cardioverter-defibrillators should be considered in patients with specific lamin A/C gene mutations to prevent sudden cardiac death.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...